Drinking at least 2 liters of water per day to stay hydrated and support kidney function
Since the first GLP-1R agonist, exenatide, was approved for the treatment of T2DM in 2005, a variety of GLP-1R agonists such as liraglutide and dulaglutide have been approved
In rare cases, more serious complications like intestinal obstruction have been reported in FDA labeling for some of these medications
Its involvement at the intersection of metabolic regulation, stress responsiveness, and reproductive endocrinology positions it as a candidate for conditions in which these domains converge, such as menopause-associated metabolic dysfunction or stress-related eating disorders
More potent medicines, such as semaglutide, tirzepatide, and liraglutide, may have superior anti-inflammatory effects